semaglutide ban 2025 Off-patent in 2026: the next revolution in anti-obesity medications Ozempic and Wegovy: How Semaglutide

In light of this, high-dose IVC has re-emerged as a potent anti-cancer agent over the past two decades, with several phase I and a few phase II clinical trials reporting high tolerability and safety with promising signs of efficacy in the treatment of various cancer types, either as monotherapy or as a combination therapy [14,15,16]

Patients with pre-existing arrhythmias, structural heart disease, or a history of significant cardiac events should discuss GLP-1 treatment with their cardiologist before starting, not just their primary care provider

insulin, a peptide hormone and drug used to treat diabetes

Bhm M, Luger T